Search Results for “Local peer support group” - Page 18

Webinar: Career pathways for young people with sight loss

Join us for our upcoming webinar!

Webinar

The cover of the Retina UK leaflet featuring a group of three people sitting around a table. There are two women and one man

Information and support

Are you affected by inherited sight loss? We are here to help.

Family planning

If you, or a close relative, are living with a genetic sight loss condition, there may be a chance that your children will inherit it.

Meet a Researcher: Dr Nikolas Pontikos

Dr Nikolas Pontikos is a Senior Research Fellow at UCL Institute of Ophthalmology, and has been working on inherited retinal conditions for several years.

Image shows three cyclists, each wearing blue and white Retina UK cycling jerseys, stood in front of the Land End sign.

Ride Reigate 2026

Cycle with #TeamRetinaUK at Ride Reigate 2026 and get behind our ground-breaking work.

Marischal College in Aberdeen, Scotland. It is a large granite building and the second largest granite building in the world.

The Kiltwalk 2026 (Aberdeen)

Join #TeamRetinaUK for an unforgettable Kiltwalk adventure in Glasgow, Aberdeen, Dundee or Edinburgh, throughout 2026.

an evening view of the revitalised Waterfront Place in Dundee, Scotland, featuring the V&A Museum of Design as its centerpiece.

The Kiltwalk 2026 (Dundee)

Join #TeamRetinaUK for an unforgettable Kiltwalk adventure in Glasgow, Aberdeen, Dundee or Edinburgh, throughout 2026.

James standing facing the camera. He is wearing a Retina UK running vest and has a medal around his neck.

Meet our supporters: James Clubb

James was part of #TeamRetinaUK in 2020 when he took part in the first ever Virtual London Marathon. He talks about his experience and his motivation.

A view of the Edinburgh skyline, dominated by the historic Edinburgh Castle.

The Kiltwalk 2026 (Edinburgh)

Join #TeamRetinaUK for an unforgettable Kiltwalk adventure in Glasgow, Aberdeen, Dundee or Edinburgh, throughout 2026.

Nanoscope Announces topline results from randomised phase 2B trial of MCO-010 for retinitis pigmentosa

Nanoscope Therapeutics has announced positive results from their two year randomised controlled phase 2b optogenetic therapy trial for late-stage retinitis pigmentosa (RP).